ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
David P. Taggart
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taggart, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taggart, D. P.
Related Collections
Right arrow Coronary disease
Right arrow Professional affairs

Ann Thorac Surg 2006;82:1966-1975
© 2006 The Society of Thoracic Surgeons

Thomas B. Ferguson Lecture

Coronary Artery Bypass Grafting is Still the Best Treatment for Multivessel and Left Main Disease, But Patients Need to Know

David P. Taggart, MD(Hons), PhD*

John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom

* Address correspondence to Dr Taggart, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom (Email: david.taggart@orh.nhs.uk).

Presented at the Forty-second Annual Meeting of The Society of Thoracic Surgeons, Chicago, IL, Jan 30–Feb 1, 2006.

The first 300 words of the full text of this article appear below.


   Introduction
 
I would like to thank the Society of Thoracic Surgery and, in particular, Dr Sydney Levitsky, the President, for the honor and privilege of presenting this Sixth Annual Thomas B. Ferguson Lecture. Dr Ferguson (Fig 1) is unquestionably one of the outstanding cardiothoracic surgeons of his generation. He is one of the few surgeons to have been both President of the AATS and STS, editor of Annals of Thoracic Surgery from 1984 to 2000, during which time he considerably raised both the academic and international profile of the journal, and is currently senior editor of CTS net.


Figure Removed (Available Only in the Full Text)
View larger version (107K):



  		Fig 1. Dr Thomas B. Ferguson.

 
The Ferguson Lecture was established by the STS in 2000 "to recognize and honor Dr Ferguson and the profound and far reaching influence of his contributions to the specialty of cardiothoracic surgery." Dr Ferguson is described by the STS as "a consummate physician and friend to his patients, a widely recognized teacher to students and residents, a respected colleague to all cardiothoracic surgeons and a leader in developing the communication capabilities essential to continuing education."

It is therefore a considerable honor and privilege to deliver this lecture. The STS stipulates that the subject matter of the lecture should address "new and powerful external forces shaping the future of patient care." Consequently, previous lectures have dealt with issues such as public and health care policy, ethics, economics, and the development and dissemination of new technologies as powerful forces impacting on how cardiothoracic surgeons care for their patients. And it is the last issue—the increasing distortion of an evidence-based surgical practice in favor of an unproven technology—that I intend to address.

I believe that the biggest threat today to patient care is the increasingly inappropriate (non-evidence-based) use of percutaneous coronary intervention (PCI) rather than coronary artery bypass grafting (CABG) . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
 Eur. J. Cardiothorac. Surg.Home page
V. Falk
The 'real world' asks for coronary artery bypass grafting
Eur. J. Cardiothorac. Surg., October 1, 2009; 36(4): 609 - 610.
[Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
P. Massoudy, M. Thielmann, N. Lehmann, A. Marr, G. Kleikamp, A. Maleszka, A. Zittermann, R. Korfer, M. Radu, A. Krian, et al.
Impact of prior percutaneous coronary intervention on the outcome of coronary artery bypass surgery: A multicenter analysis
J. Thorac. Cardiovasc. Surg., April 1, 2009; 137(4): 840 - 845.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
I. E. Konstantinov, P. Saxena, and J. Shehatha
Coronary stent disease: When will enough be enough?
J. Thorac. Cardiovasc. Surg., April 1, 2009; 137(4): 1020 - 1021.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. Kaul, W. E. Boden, T. B. Ferguson Jr, R. A. Guyton, M. J. Mack, P. T. Sergeant, R. J. Shemin, P. K. Smith, S. Yusuf, and D. P. Taggart
Reply
J. Am. Coll. Cardiol., August 12, 2008; 52(7): 584 - 586.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
N. D. Desai
Pitfalls Assessing the Role of Drug-Eluting Stents in Multivessel Coronary Disease
Ann. Thorac. Surg., January 1, 2008; 85(1): 25 - 27.
[Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
M. Thielmann, M. Neuhauser, S. Knipp, E. Kottenberg-Assenmacher, A. Marr, N. Pizanis, M. Hartmann, M. Kamler, P. Massoudy, and H. Jakob
Prognostic impact of previous percutaneous coronary intervention in patients with diabetes mellitus and triple-vessel disease undergoing coronary artery bypass surgery
J. Thorac. Cardiovasc. Surg., August 1, 2007; 134(2): 470 - 476.
[Abstract] [Full Text] [PDF]

Home page
 PerfusionHome page
F. D. Rubens and H. Nathan
Lessons learned on the path to a healthier brain: dispelling the myths and challenging the hypotheses
Perfusion, May 1, 2007; 22(3): 153 - 160.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The Society of Thoracic Surgeons.